FIRST: Novartis Launches Zero-Profit COVID-19 Medicine Portfolio To 79 Countries ruchika18 July 2020 4:00 AM GMTBasel: Novartis has announced a new initiative to help patients in low-income and lower-middle-income countries (LIC; LMIC) access affordable medi...
Unichem Labs gets USFDA nod to Baclofen Tablets for spasticity relief ruchika11 July 2020 5:38 AM GMTBaclofen Tablets are indicated for the alleviation of signs and symptoms of spasticity resulting from multiple sclerosis, particularly for the relief...
Novartis to pay over Rs 5064 crore to settle alleged doctor-bribe, price-fixing claims Farhat Nasim3 July 2020 6:37 AM GMTThe company admitted giving doctors cash, golf and fishing trips, and lavish meals at some of the nation's fanciest restaurants to induce them to...
Novartis India net profit falls 65pc to Rs 6.78 crore in Q4 ruchika22 Jun 2020 4:00 AM GMTRevenue from operations stood at Rs 93.70 crore for the quarter under consideration. It was Rs 110.38 crore for the same period a year ago, Novartis...
Glenmark Pharmaceuticals gets USFDA nod for Fingolimod Capsules ruchika19 Jun 2020 9:44 AM GMTMumbai: Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food & Drug Administration (U.S. FDA) fo...
Novartis Cosentyx gets USFDA nod to treat active non-radiographic axial spondyloarthritis ruchika17 Jun 2020 12:13 PM GMTCosentyx met the primary endpoint achieving statistically significant improvements versus placebo in the signs and symptoms of nr-axSpA, as measured...
Sandoz Canada gets approval to launch oncology biosimilars Ziextenzo, Riximyo ruchika11 Jun 2020 4:00 AM GMTSandoz Canada received a Notice of Compliance from Health Canada on April 21, 2020, for the use of Ziextenzo to reduce the incidence of febrile...
Novartis Cosentyx gets EU nod to treat active non-radiographic axial spondyloarthritis ruchika3 May 2020 4:30 AM GMTBasel: Novartis has announced the European Commission (EC) has approved Cosentyx® (secukinumab) for the treatment of adult patients with active non-rad...
Novartis Kymriah gets USFDA RMAT designation in follicular lymphoma Medical Dialogues Bureau26 April 2020 5:30 AM GMTKymriah, which is designed to be a one-time treatment, is the first-ever FDA-approved CAR-T cell therapy.
Novartis gets USFDA nod to start randomized trial of malaria drug hydroxychloroquine against COVID-19 ruchika20 April 2020 9:04 AM GMTZurich: Novartis has won the go-ahead from the U.S. Food and Drug Administration to conduct a randomized trial of malaria drug hydroxychloroquine again...
Inj Voveran Ban: Delhi High Court denies relief to manufacturer Themis Medicare, Dismisses Petition Meghna A Singhania12 July 2019 12:31 PM GMTNew Delhi: Denying relief to Themis Medicare, the manufacturer of the popular painkiller Inj Voveran 1ml (Diclofenac), that as marketed by Novartis...
9 arrested for selling drugs meant for defence, ESIC hospitals Medical Dialogues Bureau25 May 2019 4:30 AM GMTThane: The Navi Mumbai police in Maharashtra claimed to have busted an inter-state racket of illegal sale of medicines meant for defence and ESIC...
